| | |
| TOP PICK | 43.510 | Danny Tomka | Stock price has been cut in half since March/04 because of their depression drug which is coming off patent. Creating their own generic drug. Great company. Juggernaut sales force. Has about $4 of cash. Has a product ramp in alzheimers. | 2004-11-09 | |
| | |
| TOP PICK | 42.510 | John Sinkins, CFA | Had dropped because of concerns about teens using their anti-depressant. A good price. | 2004-09-13 | |
| | |
| BUY | 51.900 | Brian Milner | Buy, stick away and don't look at it for quite awhile. Costs are low on R & D because they tend to buy compounds that have already been researched. Not cheap. | 2003-05-02 | |
Experts that have talked about Forest Laboratories
Rss Top Picks Feed